logo

For the Inventor, By the Inventor

Kelkheim (Taunus), Germany

Erhardt Winkelmann

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Kelkheim, Taunus, DE (1976 - 1978)
  • Kelkeim, Taunus, DE (1978)

Company Filing History:

goldMedal17 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1976-1978

Loading Chart...
17 patents (USPTO):Explore Patents
1. 4105763 - 1-Methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles (1978-08-08),
2. 4078086 - Anthraquinone-bis-amidines and process for preparing them (1978-03-07),
3. 4057634 - Antiprotozoal(1-alkyl-5-nitro-imidazolyl-2-alkyl)-pyridazines (1977-11-08),
4. 4053482 - 1-Methyl-2-(substituted thiomethyl)-5-nitro-imidazoles (1977-10-11),
5. 4046896 - 1-Methyl-2-(pyridyl-oxymethyl)-5-nitro-imidazoles (1977-09-06),
6. 4042705 - 1-Methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles and process for their (1977-08-16),
7. 4031232 - 1-Alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and process for their (1977-06-21),
8. 4018792 - 5-Cyano-thiophen-2-aldehyde-isothiosemicarbazones and process for (1977-04-19),
9. 4001415 - Composition for and method of treating diseases caused by protozoa (1977-01-04),
10. 3992397 - (1-Alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryl compounds and process (1976-11-16),
11. 3991191 - Antiprotozoal (1-alkyl-5-nitro-imidazolyl-2-alkyl)-pyrimidines (1976-11-09),
12. 3984560 - Composition for and method of treating disease caused by protozon (1976-10-05),
13. 3984426 - (1-Alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryl compounds (1976-10-05),
14. 3973019 - Pharmaceutical compositions containing (1976-08-03),
15. 3962454 - Bis-(1-alkyl-5-nitro-imidazolyl-2-alkyl)-compounds (1976-06-08),

Title: Erhardt Winkelmann: Innovator in Pharmaceutical Chemistry

Introduction

Erhardt Winkelmann is a notable inventor based in Kelkheim (Taunus), Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various diseases. With a total of 17 patents to his name, Winkelmann's work has had a considerable impact on medical science.

Latest Patents

Winkelmann's latest patents include the invention of 1-Methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles. These new compounds are disclosed along with a process for their manufacture. They are particularly suitable for the treatment of protozoal diseases and demonstrate marked activity against helminths, ectoparasites, and ticks. Another significant patent involves anthraquinone-bis-amidines, which are novel compounds prepared to combat diseases caused by trichomonads.

Career Highlights

Winkelmann has spent a considerable part of his career at Hoechst Aktiengesellschaft, where he has been instrumental in advancing pharmaceutical research. His innovative approaches and dedication to improving health outcomes have earned him recognition in the scientific community.

Collaborations

Throughout his career, Winkelmann has collaborated with esteemed colleagues, including Wolfgang Raether and Akhileswer Sinharay. These partnerships have fostered a collaborative environment that has led to groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Erhardt Winkelmann's contributions to the field of pharmaceutical chemistry are noteworthy. His innovative patents and collaborative efforts continue to influence the treatment of various diseases. His work exemplifies the importance of research and innovation in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…